The Burrill Canadian Biotech News is a premier weekly biotechnology publication, which has been reporting on the Canadian biotech industry for over 17 years. It is the publication of record for news, events and the capital markets in Canada’s growing biotech and life sciences sectors. Its continuing commitment to an outstanding level of excellence is fueled by founder and Editor-in-Chief, Peter Winter - a bioscientist and award-winning journalist with over 25 years experience of consulting, writing and editing. He is Canada's leading expert and commentator on Canadian biotechnology and his opinions, reports and commentaries are widely sought by government organizations and companies. 

A one-year subscription to Canadian Biotech News is US$450.00. Published 48 times per year (double issues in August and December), each issue brings you the latest news and analysis on Canada’s rapidly evolving public and private companies and organizations. Your paid subscription comes with a free copy of Biotech 2007 Life Sciences: A Global Transformation (a $395 value)

Subscribers to Canadian Biotech News qualify for a 30% discount off the Canadian Biotech News Industry Report.

Download Sample Report 1 >

Download Sample Report 2 >

*Discount does not apply to reports already purchased. The prices quoted above reflect the 10% discount.